Education, Science, Technology, Innovation and Life
Open Access
Sign In

Liquid Nanoemulsion Delivery: A Technology for Accelerating the Early Systemic Availability of L-Ergothioneine in Rats

Download as PDF

DOI: 10.23977/aipps.2025.030101 | Downloads: 0 | Views: 23

Author(s)

Naizhuang Jake Wang 1, Doris Dai 1, Amelia 1, Mok Wai Fun 1

Affiliation(s)

1 Biowell R&D Center, Eternal Grace PTE.LTD, 2 Venture Drive, #08-31 Vision Exchange, Singapore, 608526

Corresponding Author

Doris Dai

ABSTRACT

This study investigated the pharmacokinetic profile of L-ergothioneine (EGT) delivered via a liquid nanoemulsion versus a conventional powder formulation in rats. Plasma concentrations were monitored over a 24-hour period following oral administration of equal doses (20 mg/kg). The nanoemulsion group demonstrated significantly accelerated absorption, with plasma levels at 0.5 h and 1 h reaching 2.51- and 3.70-fold higher, respectively, than those of the powder group. The nanoemulsion achieved its peak concentration (Cₘₐₓ = 400.3 ng/mL) at 2 h (Tₘₐₓ), whereas the powder formulation reached a lower Cₘₐₓ (300.7 ng/mL) at a later Tₘₐₓ of 4 h. After 4 h, the concentration-time profiles of both groups converged, indicating that the nanoemulsion primarily enhances the absorption rate without altering overall bioavailability (AUC). These findings confirm that nanoemulsion delivery significantly improves the early systemic exposure of EGT.

KEYWORDS

L-Ergothioneine (EGT), OCTN1 (SLC22A4) Transporter, Oral Bioavailability, Absorption Rate, Pharmacokinetics (Cmax, Tmax)

CITE THIS PAPER

Naizhuang Jake Wang, Doris Dai, Amelia, Mok Wai Fun, Liquid Nanoemulsion Delivery: A Technology for Accelerating the Early Systemic Availability of L-Ergothioneine in Rats. Advances in Industrial Pharmacy and Pharmaceutical Sciences (2025) Vol. 3: 1-5. DOI: http://dx.doi.org/10.23977/aipps.2025.030101.

REFERENCES

[1] Gründemann D, Harlfinger S, Golz S, et al. Discovery of the ergothioneine transporter . Proc Natl Acad Sci U S A. 2005;102(14):5256–5261.
[2] Halliwell B. Ergothioneine—A diet-derived antioxidant with therapeutic potential. FEBS Lett. 2018;592(20):3357–3366.
[3] Cheah IK, Tang RMY, Yew TSZ, et al. Administration of pure ergothioneine to healthy human subjects: Uptake, metabolism, and effects on biomarkers of oxidative damage and inflammation. Antioxid Redox Signal. 2017;26(5):193–206.
[4] Tucker RAJ, Cheah IK, Halliwell B, et al. Specificity of the ergothioneine transporter natively expressed in human cells. Biochim Biophys Acta—Biomembr. 2019;1861(8):1559–1566.
[5] Pochini L, Galluccio M, Scalise M, et al. OCTN1: A widely studied but still enigmatic organic cation transporter. Int J Mol Sci. 2022;23(2):914.
[6] Galluccio M, Scalise M, Pochini L, et al. The human OCTN sub-family: Gene and protein structure, expression, and physiological roles. Int J Mol Sci. 2024;25(16):8743.
[7] U.S. Food and Drug Administration (FDA). Bioavailability Studies Submitted in NDAs or INDs—General Considerations. Guidance for Industry. Final 2019; updated 2024.
[8] Pouton CW, Porter CJH. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 2008;60(6):625–637.
[9] Porter CJH, Pouton CW, Cuine JF, et al. Enhancing intestinal drug solubilisation using lipid-based delivery systems. Adv Drug Deliv Rev. 2008;60(6):673–691.
[10] Gürsoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58(3):173–182.
[11] Kohli K, Chopra S, Dhar D, et al. Self-emulsifying drug delivery systems: An approach to enhance oral bioavailability. Drug Discov Today. 2010;15(21–22):958–965.
[12] Rehman FU, Shah KU, Shah SU, et al. Thermodynamically and kinetically stable lipidic self-emulsifying formulations: principles and characterization. Pharmaceutics. 2022;14(9):1908.
[13] Cherniakov I, Domb AJ, Hoffman A. Self-nano-emulsifying drug delivery systems (SNEDDS): An update of the biopharmaceutical aspects. Expert Opin Drug Deliv. 2015;12(7):1121–1133.
[14] Müllertz A, Ogbonna A, Ren S, et al. New perspectives on lipid and surfactant-based drug delivery systems for oral delivery of poorly soluble drugs. J Pharm Pharmacol. 2010;62(11):1622–1636.

Downloads: 96
Visits: 6456

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.